Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates - Derian, CK; Damiano, BP; Addo, MF (J Pharmacol Exp Ther, 2003)
et al.